Antitumor activity of 4-Arylcoumarins from endophytic Streptomyces aureofaciens CMUAc130

Journal of Cancer Research and Therapeutics

Volumn 3, Issue 2, 2007, Pages 86-91

  Taechowisan, Thongchai ^a   Lu, Chunhua ^b   Shen, Yuemao ^c   Lumyong, Saisamorn ^d  

^a SILPAKORN UNIVERSITY   (Thailand)

^b XIAMEN UNIVERSITY   (China)

^c INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^d CHIANG MAI UNIVERSITY   (Thailand)

Author keywords

4 arylcoumarins; Antitumor activity; Endophytic streptomyces; Lewis lung carcinoma

Indexed keywords

5,7 DIMETHOXY 4 4 METHOXYPHENYLCOUMARIN; 5,7 DIMETHOXY 4 4 PHENYLCOUMARIN; COUMARIN DERIVATIVE; DOXORUBICIN; PROTEIN BAX; PROTEIN BCL 2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG STRUCTURE; FEMALE; GROWTH INHIBITION; HUMAN; HUMAN CELL; LEWIS CARCINOMA; MOUSE; NONHUMAN; PROTEIN EXPRESSION; STREPTOMYCES AUREOFACIENS; WESTERN BLOTTING;

EID: 34548684147     PISSN: 09731482     EISSN: 09731482     Source Type: Journal    
DOI: 10.4103/0973-1482.34685     Document Type: Article

References (32)

1. Murray RD, Méndez J, Brown SA. The natural coumarins. John Wiley: Chichester; 1982.
2. Inoue Y, Kondo H, Taguchi M, Jinbo Y, Sakamoto F, Tsukamoto G. Synthesis and antibacterial activity of thiazolopyrazine-incorporated tetracyclic quinolone antibacterials. J Med Chem 1994;37:586-92.
3. Jamkhandi PS, Rajagopal S. Synthesis of 4-hydroxy-l-thiacoumarins. Arch Pharm Ber Dtsch Pharm Ges 1967;300:561-6.
4. Badawi MM, Handa SS, Kinghorn AD, Cordell GA, Farnsworth NR. Plant anticancer agents XXVII: Antileukemic and cytotoxic constituents of Dirca occidentalis (Thymelaeaceae). J Pharm Sci 1983;72:1285-7.
5. Buckle DR, Cantello BC, Smith H, Spicer BA. 2-cyano-1,3-dicarbonyl compounds with antiallergic activity. J Med Chem 1977;20:265-9.
6. Jung JC, Lee JH, Oh S, Lee JG, Park OS. Synthesis and antitumor activity of 4-hydroxycoumarin derivatives. Bioorg Med Chem Lett 2004;14:5527-31.
7. Kawaii S, Tomono Y, Ogawa K, Sugiura M, Yano M, Yoshizawa Y. The antiproliferative effect of coumarins on several cancer cell lines. Anticancer Res 2001;21:917-23.
8. Taechowisan T, Lu C, Shen Y, Lumyong S. Secondary metabolites from endophytic Streptomyces aureofaciens CMUAc130 and their antifungal activity. Microbiology 2005;151:1691-5.
9. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, et al. Prevention of apoptosis by bcl-2: Release of cytochrome c from mitochondria blocked. Science 1997;275:1129-32.
10. Reed JC, Miyashita T, Takayama S, Wang HG, Sato T, Krajewiski S, et al. BCL-2 family proteins regulators of cell death involved in the pathogenesis of cancer and resistance to therapy. J Cell Biochem 1996;60:23-32.
11. Meyn RE, Stephens LC, Milas L. Programmed cell death and radioresistance. Cancer Metastasis Rev 1996;15:119-31.
12. Yoshida H, Kong YY, Yoshida R, Elia AJ, Hakem A, Hakem R, et al. Apaf-1 is required for mitochondrial pathways of apoptosis and brain development. Cell 1998;94:739-50.
13. Yamaguchi H, Wang HG. The protein kinase PKB/Akt regulates cell survival and apoptosis by inhibiting Bax conformational change. Oncogene 2001;20:7780-6.
14. Kahn J, Preis P, Waldman F, Tseng A. Coumarin modulates the cell-cycle progression of an MTV-EJras cell line. J Cancer Res Oncol 1994;120:S19-22.
15. Sedlak TW, Oltvai ZN, Yank E, Wang K, Boise LH, Thompson CB, et al. Multiple Bcl-2 family members demonstrate selective dimerizations with Bax. Proc Natl Acad Sci USA 1995;92:7834-8.
16. Zha H, Aimé-Sempé C, Sato T, Reed JC. Proapoptotic protein Bax heterodimerizes with bcl-2 and homodimerizes with Bax via a novel domain (BH3) distinct from BH1 and BH2. J Biol Chem 1996;271:7440-4.
17. Pezzella F, Turley H, Kuru I, Tungekar MH, Pierce CB, Harris A, et al. Bcl-2 protein in non-small-cell lung carcinoma. N Engl J Med 1993;329:690-4.
18. Guo B, Cao S, Toth K, Azrac RG, Rustum YM. Overexpression of Bax enhances antitumor activity of chemotherapeutic agents in human head and neck squamous cell carcinoma. Clin Cancer Res 2000;6:718-24.
19. Taechowisan T, Lumyong S. Activity of endophytics actinomycetes from roots of Zingiber officinale and Alpinia galanga against phytopathogenic fungi. Ann Microbiol 2003;53:291-8.
20. Taechowisan T, Peberdy JF, Lumyong S. Isolation of endophytic actinomycetes from selected plants and their antifungal activity. World J Microbiol Biotechnol 2003;19:381-5.
21. Shirling EB, Gottlieb D. Methods for characterization of Streptomyces species. Int J Syst Bacteriol 1966;16:313-40.
22. Kato T, Sato K, Kakinuma H, Matsuda Y. Enhanced suppression of tumor growth by combination of angiogenesis inhibitor O-(chloroacetyl-carbamoyl) fumagillol (TNP-470) and cytotoxic agents in mice. Cancer Res 1994;54:5143-7.
23. Mosmann T. Rapid colorimetric assay for cellular growth and survival: Applications to proloferation and cytotoxicity assay. J Immunol 1983;65:55-63.
24. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate phenol chloroform extraction. Anal Biochem 1986;162:156-9.
25. Peterson GL. Determination of total protein. Methods Enzymol 1983;81:95-119.
26. Mora A, Paya M, Rios JL, Alcaraz MJ. Structure-activity relationships of polymethoxyflavones and other flavonoids as inhibitors of nonenzymic lipid peroxidation. Biochem Pharmacol 1990;40:793-7.
27. Hoult JR, Paya M. Pharmacological and biochemical actions of simple coumarins: Natural products with therapeutic potential. Gen Pharmacol 1996;27:713-22.
28. Visser LE, Trienekens PH, De Smet PA, Vulto AG, Hofman A, van Duijn CM. et al. Patients with an ApoE epsilon4 allele require lower doses of coumarin anticoagulants. Pharmacogenet Genomics 2000;15:69-74.
29. Nicolaides DN, Gautam DR, Litinas KE, Hadjipavlou-Litina DJ, Fylaktakidou, KC. Synthesis and evaluation of the antioxidant and antiinflammatory activities of some benzo[l]khellactone derivatives and analogues. Eur J Med Chem 2004;39:323-32.
30. Kontogiorgis CA, Hadjipavlou-Litina DJ. Synthesis and biological evaluation of novel coumarin derivatives with a 7-azomethine linkage. Bioorg Med Chem Lett 2004;14:611-4.
31. Fylaktakidou KC, Hadjipavlou-Litina DJ, Litinas KE, Nicolaides DN. Natural and synthetic coumarin derivatives with anti-inflammatory/antioxidant activities. Curr Pharm Des 2004;10:3813-33.
32. Zänker KS. Coumarin(s) interface between cell growth inhibition, expression of oncogenes, tumour cell locomotion and cell-to-cell communication. Irish Coll Phys Surg 1993;22:51-5.